ORKA compared with SYRE: revenue, margins and what each company keeps, and the suppliers and customers both name

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ORKAOruka Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closes · 499dMethod ›

Moved together

ORKAwithSYRE

×0.47co-movement · SYRE on ORKA · 499d

r 0.53scale to r 0.75

Shared co-movers4with ORKAwith SYRE

APGEApogee Therapeutics, Inc.r 0.42r 0.52

CGONCG Oncology, Inc.r 0.41r 0.48

XNCRXencor Incr 0.39r 0.45

NRIXNurix Therapeutics, Inc.r 0.36r 0.46

ORKA, solidSYRE, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

Mkt cap$6.4B

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

ClosedOct 30 '26

Mkt cap$8.5B

Compare

ClosedOct 30 '26

ORKAOruka Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

96.24▼−0.42%post 98.76

Price

96.44▼−2.55%

$6.4B

Mkt cap

$8.5B

ORKA96.24▼−0.42%vsSYRE96.44▼−2.55%ClosedOct 30 '26